ASTH vs XYL · P/E 34, rev $1.94B vs P/E 27, rev $4.46B
Astrana Health Inc (ASTH) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Astrana Health Inc (ASTH) is a medical care facilities company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported ASTH revenue for 2026-06-30 was $1.94B. Net income was $34.2M. ASTH currently screens at market cap $1.13B and trailing P/E 33.5.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
ASTH currently screens at market cap $1.13B and trailing P/E 33.5. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the ASTH and XYL stock pages for the full models.
Not investment advice.